Kenvue Inc. $KVUE Shares Acquired by Geode Capital Management LLC

Geode Capital Management LLC increased its stake in Kenvue Inc. (NYSE:KVUE) by 1.2% in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 49,001,887 shares of the company’s stock after purchasing an additional 604,953 shares during the quarter. Geode Capital Management LLC owned 2.55% of Kenvue worth $1,021,267,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in the stock. Vanguard Group Inc. increased its holdings in Kenvue by 4.9% in the first quarter. Vanguard Group Inc. now owns 229,144,387 shares of the company’s stock valued at $5,494,882,000 after buying an additional 10,600,682 shares in the last quarter. Third Point LLC purchased a new stake in shares of Kenvue during the 1st quarter worth approximately $213,422,000. Maverick Capital Ltd. acquired a new stake in shares of Kenvue in the 1st quarter worth approximately $203,036,000. Nuveen LLC purchased a new position in Kenvue in the 1st quarter valued at approximately $187,123,000. Finally, Voya Investment Management LLC increased its stake in Kenvue by 131.3% in the 1st quarter. Voya Investment Management LLC now owns 12,131,468 shares of the company’s stock valued at $290,557,000 after purchasing an additional 6,886,784 shares in the last quarter. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Analysts Set New Price Targets

A number of analysts have commented on the company. Barclays boosted their target price on Kenvue from $17.00 to $18.00 and gave the stock an “equal weight” rating in a research report on Monday. Jefferies Financial Group decreased their price objective on shares of Kenvue from $25.00 to $23.00 and set a “buy” rating on the stock in a research report on Monday, October 27th. Edward Jones cut shares of Kenvue from a “strong-buy” rating to a “hold” rating in a research note on Monday, November 3rd. Redburn Partners set a $22.00 target price on shares of Kenvue in a research report on Friday, September 26th. Finally, UBS Group lowered their price target on shares of Kenvue from $23.00 to $17.00 and set a “neutral” rating on the stock in a research report on Wednesday, October 8th. One investment analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating, twelve have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $20.23.

Kenvue Price Performance

Kenvue stock opened at $16.77 on Friday. The stock has a market capitalization of $32.13 billion, a P/E ratio of 22.36, a P/E/G ratio of 2.43 and a beta of 0.71. Kenvue Inc. has a 12-month low of $14.02 and a 12-month high of $25.17. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.98 and a quick ratio of 0.69. The firm’s 50-day moving average is $16.46 and its two-hundred day moving average is $20.13.

Kenvue (NYSE:KVUE) last posted its quarterly earnings data on Monday, November 3rd. The company reported $0.28 earnings per share for the quarter, beating analysts’ consensus estimates of $0.27 by $0.01. Kenvue had a net margin of 9.55% and a return on equity of 20.02%. The business had revenue of $3.76 billion during the quarter, compared to analyst estimates of $3.83 billion. During the same quarter in the previous year, the business posted $0.28 earnings per share. The company’s revenue was down 3.5% on a year-over-year basis. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. Equities analysts predict that Kenvue Inc. will post 1.14 earnings per share for the current year.

Kenvue Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, November 26th. Shareholders of record on Wednesday, November 12th will be paid a dividend of $0.2075 per share. This represents a $0.83 dividend on an annualized basis and a dividend yield of 4.9%. The ex-dividend date of this dividend is Wednesday, November 12th. Kenvue’s dividend payout ratio is currently 110.67%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.